0
0
GURUGRAM, HARYANA — A local couple has plunged into a profound public health and legal crisis after routinely requested genetic testing confirmed that their twin daughters, born through in vitro fertilization (IVF) in January 2026, share no biological connection with either parent. On June 10, 2026, Rahul and Meenu Rathore approached a Delhi court, alleging that a prominent fertility clinic in Greater Kailash, Delhi, interchanged their embryos during a procedure handled by Dr. Shivani Sachdev Gour. The court has since ordered local authorities to initiate a criminal investigation, while the Delhi government’s Appropriate Authority under the Assisted Reproductive Technology (ART) and Surrogacy Act has launched formal regulatory proceedings.
The case has sent shockwaves through India’s rapidly expanding fertility sector, shifting public attention toward the systemic, psychological, and regulatory safeguards intended to protect families undergoing assisted reproduction.
The Discovery: A Devastating Mismatch
The Rathores initiated their fertility treatment in January 2025, leading to a successful embryo transfer on May 14, 2025. Mrs. Rathore carried the pregnancy to term, giving birth to twin girls on January 5, 2026.
The initial discovery arose from observations regarding the children’s physical appearance.
“Initially, we noticed the children bore no physical resemblance to us,” the family stated, explaining what eventually prompted them to seek DNA testing—a gold-standard medical protocol used to establish definitive biological relationships.
The laboratory analysis delivered a catastrophic revelation: a complete genetic mismatch, confirming that neither parent is biologically related to the infants. The family’s legal filings allege that the facility either implanted embryos belonging to another couple or misplaced the infants immediately following delivery.
“Just as I am searching for my child, the mother whose child I have must also be yearning for them,” Meenu Rathore shared in an emotional interview with NDTV. Despite the profound distress, which she noted compromised her ability to breastfeed, she added: “Even though these girls are not ours, we are taking care of them.”
The family describes the ordeal as destabilizing, noting they have since received communications from families worldwide sharing similar accounts of regulatory or institutional failure.
Inside the IVF Lab: How Mismatches Occur
While the Rathore case represents an extreme manifestation of clinical error, reproductive endocrinologists emphasize that such events remain statistically rare, though deeply impactful.
“IVF laboratory errors are statistically uncommon but carry outsized weight when they occur,” explains Dr. Amanda Chen, a reproductive endocrinologist at the Mayo Clinic who is not involved in the case.
Dr. Chen points to large-scale data showing that approximately 99.96% of individual procedures and 99.77% of overall treatment cycles occur without moderate or significant deviations from protocol.
“Still, a mismatch rate of 0.19%—seemingly negligible—carries devastating consequences when it involves potential wrongful parentage,” Dr. Chen notes.
According to senior embryologists, handling human gametes (eggs and sperm) and embryos requires highly repetitive, multi-step manipulation under sterile laboratory environments.
“Each step in an IVF cycle demands careful tracking of biological materials,” says Dr. Rajesh Kumar, a senior embryologist at the All India Institute of Medical Sciences (AIIMS), New Delhi. “Traditionally, this process relied on manual double-witnessing systems, with two staff members confirming each identification step. While effective, human oversight is not immune to fatigue or distraction—especially in high-volume centers.”
To mitigate human error, modern fertility frameworks utilize comprehensive chain-of-custody protocols:
-
The Two-Person Rule: Requiring two independent practitioners to verify the patient’s name, identification numbers, and corresponding dish or tube labels before any biomaterial is moved.
-
Mandatory Witnessing Points: Strict protocols enforced during high-risk stages, specifically egg retrieval, sperm processing, embryo freezing or thawing, and final embryo transfer.
-
Electronic Witnessing Systems: The integration of radio-frequency identification (RFID) tags or barcoding systems that monitor lab dishes in real time, locking the workstation or sounding an alarm if unmatched samples are placed in proximity.
Peer-reviewed evaluations indicate that combining electronic RFID tracking with automated tools can lower mismatch risks to approximately 0.11%, highlighting the value of technological interventions over purely manual tracking.
The Regulatory Framework: India’s ART Act
India’s fertility sector operates under the Assisted Reproductive Technology (Regulation) Act, 2021, which was enacted in December 2021 to provide a formal legal infrastructure for clinics and banks nationwide.
The legislation introduces clear operational mandates:
| Requirement | Statutory Description |
| Mandatory Registration | All operating ART clinics and banks must be registered with national and state authorities to ensure compliance with basic infrastructure standards. |
| Strict Record Keeping | Facilities must maintain comprehensive, traceable logs of all clinical procedures, donor matchings, and laboratory interventions. |
| Severe Penalties | Section 33 of the Act establishes fines ranging from ₹5 lakh to ₹25 lakh, along with potential imprisonment up to 10 years, for serious violations or commercial exploitation. |
| Legal Parentage Protection | The Act explicitly presumes the commissioning couple to be the legal parents of the child, establishing immediate legal protections for children born via ART, even in cases involving technical or administrative errors. |
Under the current legal framework, aggrieved patients can pursue multi-tiered recourse, directing complaints to District ART Boards, State ART Authorities, Consumer Courts, or State Medical Councils.
Precedents and Public Health Concerns
The unfolding situation in Gurugram reflects systemic vulnerabilities previously documented within the Indian consumer court system. In 2023, the National Consumer Disputes Redressal Commission (NCDRC) issued a landmark ruling fining a West Delhi hospital ₹1.5 crore after a semen sample mix-up resulted in twins who were not biologically related to the husband. In a separate, earlier case, another Delhi hospital faced an identical ₹1.5 crore penalty after DNA profiling proved that the sperm used during an IVF cycle belonged to an anonymous third party rather than the intended parent.
Public health advocates argue that these incidents underscore broader structural issues within a highly commercialized fertility ecosystem.
Some public health experts note that parts of the fertility sector have been commercialized aggressively, with certain facilities prioritizing high-volume cycles over rigorous quality management systems. Furthermore, standard reporting mechanisms across the industry remain inconsistent, allowing some clinics to omit data on canceled cycles or manipulate patient selection to obscure operational challenges. A significant proportion of laboratory anomalies are believed to occur within smaller, under-regulated facilities that operate on the fringes of the ART Act’s registration requirements.
The Trauma of Fertility Disruption
Beyond the legal and administrative battles, the emotional burden of genetic mismatch places an immense strain on families.
“Clients navigating assisted reproductive technologies may present with grief that lacks clear endpoints, disruptions to identity and life narrative, strain within intimate relationships, and symptoms consistent with trauma responses,” explains Dr. Sarah Williams, a psychologist specializing in fertility trauma at Harvard Medical School.
Clinical research demonstrates that repeated, unsuccessful or complicated fertility interventions often induce chronic stress, anxiety, and depressive symptoms that closely mirror post-traumatic stress responses. Because couples frequently exhibit divergent coping mechanisms, such structural clinical failures can severely test familial cohesion.
Limitations and Ongoing Proceedings
As the legal process begins, medical and legal experts emphasize the need for balanced interpretation while investigations remain active:
-
The allegations against the Greater Kailash facility remain under formal examination by both the local police and the designated ART Appropriate Authority; no definitive judicial or regulatory conclusion of negligence has yet been reached.
-
The clinic has not issued a public statement addressing the specific mechanics of the alleged sample interchange.
-
Comprehensive global data tracking absolute IVF error rates remains incomplete, as many centers resolve disputes through private arbitration, making exact baseline comparisons difficult to establish.
Currently, the Rathore family has sought the intervention of Delhi Chief Minister Rekha Gupta to secure an impartial, accelerated investigation, including the formal preservation of all underlying laboratory logs, electronic tracking data, and CCTV recordings from the period of treatment.
Guidance for Intended Parents
For individuals and couples currently undergoing or considering assisted reproduction, reproductive experts recommend taking specific proactive steps:
-
Verify Official Accreditation: Confirm that the fertility center is fully registered and compliant under the ART (Regulation) Act, 2021 through state health registries.
-
Audit Laboratory Practices: Inquire directly about the facility’s tracking infrastructure. Specifically ask if they utilize automated electronic witnessing systems (RFID or barcodes) or rely strictly on manual double-checks.
-
Request Chain-of-Custody Documentation: Maintain a comprehensive file of all cycle logs, embryology sheets, and signed verification documents detailing sample handling.
-
Seek Clear Communication: Ensure the clinical team clearly explains the safety protocols in place at critical touchpoints, such as egg retrieval and embryo transfer.
As clinical automation continues to advance, the industry is gradually moving toward more error-resistant workflows. However, as embryologists emphasize, maintaining rigorous attention to preventative protocols remains essential to ensuring that even the rarest errors are systematically prevented.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
NDTV, Times Now, and The Shillong Times News Desks: On-the-ground reportage, court-filing verification, and direct interviews conducted with the Rathore family between June 12 and June 15, 2026.
